GlaxoSmithKline is the world's fourth largest pharmaceutical company that was formed by the merger of GlaxoWellcome plc and SmithKline Beecham plc.
It is a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional drinks, and over the counter medicines.
London Markets: FTSE 100 extends gains, helped by Glaxo, utilities
May 25 - MarketWatch
HGSI fights GSK bid with ‘poison pill’
May 17 - Financial Times
Witty targets HGS with first hostile bid
May 11 - Financial Times
Glaxo takes £1.6bn Genome bid fully hostile
May 09 - Independent
Glaxo makes $2.6bn hostile bid for Human Genome
May 09 - Independent
GSK's hostile $2.6 bn bid for Human Genome Sciences
May 09 - France24
GlaxoSmithKline says net profits drop 13% in Q1
Apr 25 - France24
Glaxo gets hostile in bid for HGS
Apr 19 - Independent
Glaxo bids $2.6 bn for pharmaceutical rival
Apr 19 - France24
Human Genome Sciences rejects takeover bid
Apr 19 - CNN Money
London Markets: FTSE off after China data; banks, Vodafone decline
Apr 13 - MarketWatch
GlaxoSmithKline to create 1,000 jobs at Cumbria biopharm factory
Mar 22 - Independent
GSK announces plan to create 1,000 jobs
Mar 22 - Financial Times
GlaxoSmithKline to build UK biopharm factory
Mar 22 - Independent
Glaxo teams up for biotech fund
Mar 21 - Independent
Glaxo cuts consumer brand portfolio
Mar 15 - Independent
Glaxo thinks big with joint Japanese vaccines venture
Mar 02 - Independent
Glaxo Settles Almost 25,000 Avandia Cases Under Mediation
Feb 15 - Business Week
GlaxoSmithKline profits triple to £5.26 bn
Feb 07 - France24
Glaxo Sales Miss Estimates; Share Buyback Smaller Than 2011
Feb 07 - Business Week
By Reuters UK
The stock market slumped to its lowest level this year on Monday and looked poised for further falls, with cheap valuations unlikely to lure back investors while concerns persist over Europe's debt and the health of the global economy. (May 14)
MORE TOPICS: BARCLAYS, JPMORGAN CHASE, FTSE
By Reuters UK
Equities slumped to their lowest level this year on Wednesday and faced further losses amid downbeat corporate reports and concerns about the health of the euro zone, Britain's biggest export market. (May 09)
MORE TOPICS: CHINA, FTSE, RETAIL SALES, RETAIL, MANAGEMENT, LONDON
By Reuters
GlaxoSmithKline will take its $2.6 billion bid for long-time partner Human Genome Sciences direct to shareholders this week, after its takeover offer was rejected last month by the U.S. biotech group's board. (May 09)
MORE TOPICS: GOLDMAN SACHS, MORGAN STANLEY, FTSE, NEW YORK, CREDIT SUISSE, LONDON
By IBTimes
GlaxoSmithKline Plc (NYSE: GSK) will begin a $2.6 billion hostile takeover bid for Human Genome Sciences (NASDAQ: HGSI), the company announced Wednesday. (May 09)
MORE TOPICS: GOLDMAN SACHS, NYSE, CREDIT SUISSE, LONDON, MANAGEMENT
By IBTimes UK
GlaxoSmithKline, the British pharmaceutical company, will approach shareholders directly after the HGS board rejected its $2.6bn takeover bid. (May 09)
MORE TOPICS: INVESTMENT
By Reuters UK
Equities dropped to 2012 lows on Wednesday and looked poised for further losses in the face of downbeat corporate reports and concerns about the health of both the domestic economy and the euro zone, Britain's biggest export market. (May 09)
MORE TOPICS: FTSE, RETAIL SALES, RETAIL, MANAGEMENT, LONDON
By Reuters
Stock index futures pointed to a lower open on Wall Street on Wednesday, with futures for the S&P 500 down 0.6 percent, Dow Jones futures 0.3 percent weaker, and Nasdaq 100 futures off 0.5 percent at 04:54 a.m. EDT (0854 GMT). (May 09)
MORE TOPICS: DOW JONES, IMF, JPMORGAN CHASE, CISCO SYSTEMS
By Reuters UK
GlaxoSmithKline will take its $2.6 billion (1.6 billion pounds) bid for Human Genome Sciences direct to shareholders this week, after its takeover offer was rejected last month by the U.S. biotech group's board. (May 09)
MORE TOPICS: GOLDMAN SACHS, MORGAN STANLEY, CREDIT SUISSE
By Reuters UK
A rally by heavyweight banks and miners dragged the top share index modestly higher on Wednesday, with the market mainly steadying following sharp falls in the previous two sessions. (May 09)
MORE TOPICS: HSBC, FTSE, RETAIL SALES, RETAIL, COPPER, MANAGEMENT
By Reuters UK
A rally by recently hard-pressed banks dragged the top share index modestly higher in early deals on Wednesday following sharp falls in the previous session. (May 09)
MORE TOPICS: FTSE, MANAGEMENT
Free Edition
TAKE A TOURStay connected with the IBTimes using your favorite social networks and online news applications:
We value your privacy. Your email address will not be shared.
